 | • レポートコード：QYR9ST04421 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、慢性特発性骨髄線維症の世界市場について調査・分析し、慢性特発性骨髄線維症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、生物療法、その他）、用途別（病院、診療所、研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性特発性骨髄線維症市場動向 ・主要企業別マーケットシェア ・慢性特発性骨髄線維症の種類別市場規模2014-2019 （化学療法、生物療法、その他） ・慢性特発性骨髄線維症の用途別市場規模2014-2019 （病院、診療所、研究機関） ・慢性特発性骨髄線維症の北米市場：主要企業・種類別/用途別市場規模 ・慢性特発性骨髄線維症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・慢性特発性骨髄線維症の中国市場：主要企業・種類別/用途別市場規模 ・慢性特発性骨髄線維症の日本国内市場：主要企業・種類別/用途別市場規模 ・慢性特発性骨髄線維症の東南アジア市場：主要企業・種類別/用途別市場規模 ・慢性特発性骨髄線維症のインド市場：主要企業・種類別/用途別市場規模 ・慢性特発性骨髄線維症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （S-BIO、YM BioSciences、Sanofi、Onyx Pharmaceuticals） ・慢性特発性骨髄線維症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively affect on the development of white blood cells (WBCs), red blood cells (RBCs) and platelets. The condition of idiopathic myelofibrosis may ultimately lead to the risk of acute myelogenous leukemia. Risk of idiopathic myelofibrosis is more in geriatric population as compared to children and adult population. Patients may develop symptoms such as weakness, weight loss, night sweats, hypertension and others. Blood chemistry tests, bone marrow aspiration, molecular testing and biopsy are useful diagnostic tools to diagnose and detect chronic idiopathic myelofibrosis. Patients with idiopathic myelofibrosis are advised to take drugs like hydroxyurea, interferon alfa, androgens, prednisone and others in order to treat this disorder. In addition, stem cell transplant and splenectomy is performed by physicians in severe cases of chronic idiopathic myelofibrosis.The market of chronic idiopathic myelofibrosis is majorly driven by consistent efforts of key players to develop new and effective therapeutics. In addition, strategic collaboration and acquisition adopted by key players will further act as a driving factor for this market.
In 2018, the global Chronic Idiopathic Myelofibrosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Chronic Idiopathic Myelofibrosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Idiopathic Myelofibrosis development in United States, Europe and China.
The key players covered in this study
S-BIO
YM BioSciences
Sanofi
Onyx Pharmaceuticals
…
Market segment by Type, the product can be split into
Chemotherapy
Biological Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Chronic Idiopathic Myelofibrosis status, future forecast, growth opportunity, key market and key players.
To present the Chronic Idiopathic Myelofibrosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Chronic Idiopathic Myelofibrosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Idiopathic Myelofibrosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Biological Therapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Chronic Idiopathic Myelofibrosis Market Size
2.2 Chronic Idiopathic Myelofibrosis Growth Trends by Regions
2.2.1 Chronic Idiopathic Myelofibrosis Market Size by Regions (2014-2025)
2.2.2 Chronic Idiopathic Myelofibrosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Chronic Idiopathic Myelofibrosis Market Size by Manufacturers
3.1.1 Global Chronic Idiopathic Myelofibrosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chronic Idiopathic Myelofibrosis Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Idiopathic Myelofibrosis Key Players Head office and Area Served
3.3 Key Players Chronic Idiopathic Myelofibrosis Product/Solution/Service
3.4 Date of Enter into Chronic Idiopathic Myelofibrosis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019)
4.2 Global Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019)
5 United States
5.1 United States Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
5.2 Chronic Idiopathic Myelofibrosis Key Players in United States
5.3 United States Chronic Idiopathic Myelofibrosis Market Size by Type
5.4 United States Chronic Idiopathic Myelofibrosis Market Size by Application
6 Europe
6.1 Europe Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
6.2 Chronic Idiopathic Myelofibrosis Key Players in Europe
6.3 Europe Chronic Idiopathic Myelofibrosis Market Size by Type
6.4 Europe Chronic Idiopathic Myelofibrosis Market Size by Application
7 China
7.1 China Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
7.2 Chronic Idiopathic Myelofibrosis Key Players in China
7.3 China Chronic Idiopathic Myelofibrosis Market Size by Type
7.4 China Chronic Idiopathic Myelofibrosis Market Size by Application
8 Japan
8.1 Japan Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
8.2 Chronic Idiopathic Myelofibrosis Key Players in Japan
8.3 Japan Chronic Idiopathic Myelofibrosis Market Size by Type
8.4 Japan Chronic Idiopathic Myelofibrosis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
9.2 Chronic Idiopathic Myelofibrosis Key Players in Southeast Asia
9.3 Southeast Asia Chronic Idiopathic Myelofibrosis Market Size by Type
9.4 Southeast Asia Chronic Idiopathic Myelofibrosis Market Size by Application
10 India
10.1 India Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
10.2 Chronic Idiopathic Myelofibrosis Key Players in India
10.3 India Chronic Idiopathic Myelofibrosis Market Size by Type
10.4 India Chronic Idiopathic Myelofibrosis Market Size by Application
11 Central & South America
11.1 Central & South America Chronic Idiopathic Myelofibrosis Market Size (2014-2019)
11.2 Chronic Idiopathic Myelofibrosis Key Players in Central & South America
11.3 Central & South America Chronic Idiopathic Myelofibrosis Market Size by Type
11.4 Central & South America Chronic Idiopathic Myelofibrosis Market Size by Application
12 International Players Profiles
12.1 S-BIO
12.1.1 S-BIO Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Idiopathic Myelofibrosis Introduction
12.1.4 S-BIO Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)
12.1.5 S-BIO Recent Development
12.2 YM BioSciences
12.2.1 YM BioSciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Idiopathic Myelofibrosis Introduction
12.2.4 YM BioSciences Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)
12.2.5 YM BioSciences Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Idiopathic Myelofibrosis Introduction
12.3.4 Sanofi Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Onyx Pharmaceuticals
12.4.1 Onyx Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Idiopathic Myelofibrosis Introduction
12.4.4 Onyx Pharmaceuticals Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)
12.4.5 Onyx Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Chronic Idiopathic Myelofibrosis Key Market Segments
Table Key Players Chronic Idiopathic Myelofibrosis Covered
Table Global Chronic Idiopathic Myelofibrosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Chronic Idiopathic Myelofibrosis Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Biological Therapy Figures
Table Key Players of Biological Therapy
Figure Others Figures
Table Key Players of Others
Table Global Chronic Idiopathic Myelofibrosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Institutes Case Studies
Figure Chronic Idiopathic Myelofibrosis Report Years Considered
Table Global Chronic Idiopathic Myelofibrosis Market Size 2014-2025 (Million US$)
Figure Global Chronic Idiopathic Myelofibrosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Chronic Idiopathic Myelofibrosis Market Size by Regions 2014-2025 (Million US$)
Table Global Chronic Idiopathic Myelofibrosis Market Size by Regions 2014-2019 (Million US$)
Table Global Chronic Idiopathic Myelofibrosis Market Share by Regions 2014-2019
Figure Global Chronic Idiopathic Myelofibrosis Market Share by Regions 2014-2019
Figure Global Chronic Idiopathic Myelofibrosis Market Share by Regions 2019
Table Market Top Trends
Table Global Chronic Idiopathic Myelofibrosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Chronic Idiopathic Myelofibrosis Market Share by Manufacturers (2014-2019)
Figure Global Chronic Idiopathic Myelofibrosis Market Share by Manufacturers in 2018
Table Global Chronic Idiopathic Myelofibrosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chronic Idiopathic Myelofibrosis Product/Solution/Service
Table Date of Enter into Chronic Idiopathic Myelofibrosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table Global Chronic Idiopathic Myelofibrosis Market Size Share by Type (2014-2019)
Figure Global Chronic Idiopathic Myelofibrosis Market Size Market Share by Type (2014-2019)
Table Global Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table Global Chronic Idiopathic Myelofibrosis Market Size Share by Application (2014-2019)
Figure Global Chronic Idiopathic Myelofibrosis Market Size Market Share by Application (2014-2019)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Application in 2018
Figure United States Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table United States Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table United States Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table United States Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table United States Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table United States Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table United States Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Figure Europe Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table Europe Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table Europe Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table Europe Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table Europe Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Figure China Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table China Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table China Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table China Chronic Idiopathic Myelofibrosis Market Size by Type (2014-20189) (Million US$)
Table China Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table China Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table China Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Figure Japan Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table Japan Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table Japan Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table Japan Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table Japan Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Figure Southeast Asia Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table Southeast Asia Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table Southeast Asia Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Figure India Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table India Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table India Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table India Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table India Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table India Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table India Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Figure Central & South America Chronic Idiopathic Myelofibrosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Chronic Idiopathic Myelofibrosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Chronic Idiopathic Myelofibrosis Market Share (2018-2019)
Table Central & South America Chronic Idiopathic Myelofibrosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Chronic Idiopathic Myelofibrosis Market Share by Type (2014-2019)
Table Central & South America Chronic Idiopathic Myelofibrosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Chronic Idiopathic Myelofibrosis Market Share by Application (2014-2019)
Table S-BIO Company Details
Table S-BIO Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019) (Million US$)
Figure S-BIO Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2014-2019)
Table S-BIO Recent Development
Table YM BioSciences Company Details
Table YM BioSciences Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)(Million US$)
Figure YM BioSciences Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2014-2019)
Table YM BioSciences Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2014-2019)
Table Sanofi Recent Development
Table Onyx Pharmaceuticals Company Details
Table Onyx Pharmaceuticals Revenue in Chronic Idiopathic Myelofibrosis Business (2014-2019)(Million US$)
Figure Onyx Pharmaceuticals Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2014-2019)
Table Onyx Pharmaceuticals Recent Development
Table Global Chronic Idiopathic Myelofibrosis Market Size by Regions (Million US$) 2019-2025
Figure Global Chronic Idiopathic Myelofibrosis Market Size Share by Regions (2019-2025)
Figure Global Chronic Idiopathic Myelofibrosis Market Size Share by Regions in 2025
Figure United States Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Figure China Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Figure India Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Chronic Idiopathic Myelofibrosis Market Size Forecast (2019-2025)(Million USD)
Table Global Chronic Idiopathic Myelofibrosis Market Size by Product (2019-2025) (Million US$)
Figure Global Chronic Idiopathic Myelofibrosis Market Size by Product (2019-2025)
Figure Global Chronic Idiopathic Myelofibrosis Market Size by Product in 2025
Table Global Chronic Idiopathic Myelofibrosis Market Size by Application (2019-2025) (Million US$)
Figure Global Chronic Idiopathic Myelofibrosis Market Size by Application (2019-2025)
Figure Global Chronic Idiopathic Myelofibrosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
骨髄線維症治療の世界市場：市場規模・現状・予測 Myelofibrosis or osteomyelofibrosis is a myeloproliferative disorder which is characterized by proliferation of abnormal clone of hematopoietic stem cells. Myelofibrosis is a rare type of chronic leukemia which affects the blood forming function of the bone marrow tissue. The disorder is found to oc…- 特発性肺線維症の世界市場：市場規模・現状・予測 Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.An increase in the incidence and prevalence of fibrotic diseases is the primary driver …
- 特発性頭蓋内高血圧症治療の世界市場：市場規模・現状・予測 Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…
- 慢性閉塞性肺疾患の世界市場：市場規模・現状・予測 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.The…
- 慢性疾患管理の世界市場：市場規模・現状・予測 Chronic Disease Management which was also known as enhanced primary care earlier is the ongoing care and support which help in managing the health care of patient suffering with chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It also require visits and support…